Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-07-01falsePharmacy109falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 05399367 2024-07-01 2025-03-31 05399367 2023-07-01 2024-06-30 05399367 2025-03-31 05399367 2024-06-30 05399367 c:Director4 2024-07-01 2025-03-31 05399367 d:Buildings d:LongLeaseholdAssets 2024-07-01 2025-03-31 05399367 d:Buildings d:LongLeaseholdAssets 2025-03-31 05399367 d:Buildings d:LongLeaseholdAssets 2024-06-30 05399367 d:FurnitureFittings 2024-07-01 2025-03-31 05399367 d:FurnitureFittings 2025-03-31 05399367 d:FurnitureFittings 2024-06-30 05399367 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-07-01 2025-03-31 05399367 d:OwnedOrFreeholdAssets 2024-07-01 2025-03-31 05399367 d:CurrentFinancialInstruments 2025-03-31 05399367 d:CurrentFinancialInstruments 2024-06-30 05399367 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 05399367 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 05399367 d:ShareCapital 2025-03-31 05399367 d:ShareCapital 2024-06-30 05399367 d:RetainedEarningsAccumulatedLosses 2025-03-31 05399367 d:RetainedEarningsAccumulatedLosses 2024-06-30 05399367 c:FRS102 2024-07-01 2025-03-31 05399367 c:AuditExempt-NoAccountantsReport 2024-07-01 2025-03-31 05399367 c:FullAccounts 2024-07-01 2025-03-31 05399367 c:PrivateLimitedCompanyLtd 2024-07-01 2025-03-31 05399367 e:PoundSterling 2024-07-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 05399367










IXWORTH MEDICAL SERVICES LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2025

 
IXWORTH MEDICAL SERVICES LIMITED
REGISTERED NUMBER:05399367

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

31 March
30 June
2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
7,038
7,660

  
7,038
7,660

Current assets
  

Stocks
  
9,730
8,405

Debtors: amounts falling due within one year
 5 
143,760
159,146

Cash at bank and in hand
 6 
29,079
60,958

  
182,569
228,509

Creditors: amounts falling due within one year
 7 
(188,425)
(210,087)

Net current (liabilities)/assets
  
 
 
(5,856)
 
 
18,422

Total assets less current liabilities
  
1,182
26,082

Provisions for liabilities
  

Deferred tax
  
(1,760)
(1,455)

  
 
 
(1,760)
 
 
(1,455)

Net (liabilities)/assets
  
(578)
24,627


Capital and reserves
  

Called up share capital 
  
840
840

Profit and loss account
  
(1,418)
23,787

  
(578)
24,627


Page 1

 
IXWORTH MEDICAL SERVICES LIMITED
REGISTERED NUMBER:05399367
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr V Chandraraj
Director

Date: 4 December 2025

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
IXWORTH MEDICAL SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025

1.


General information

Ixworth Medical Services Limited is a private company limited by shares and incorporated in England and Wales, registration number 05399367. The registered office is Ixworth Surgery, Peddars Close, Ixworth, Bury St Edmunds, Suffolk, IP31 2HD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The following principal accounting policies have been applied:

 
2.2

Going concern

The Directors have considered the Company’s position at the time of signing the financial statements. They have considered future trading expectations, the current financial position of the Company and other factors such as mitigating ongoing costs.
Based on this, the Directors have concluded that the company will have adequate resources to continue in operational existence for at least twelve months from the date of signing these financial statements and will therefore adopt the going concern basis of accounting in preparing these financial statements.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 3

 
IXWORTH MEDICAL SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Current and deferred taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Improvements to leasehold
-
20 years
Fixtures, fittings & equipment
-
10% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
IXWORTH MEDICAL SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.                           
At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.11

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Page 5

 
IXWORTH MEDICAL SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the period was 10 (2024 - 9).


4.


Tangible fixed assets







Improv to 
Leasehold
Fixtures, fittings & equipment
Total

£
£
£



Cost or valuation


At 1 July 2024
11,908
6,174
18,082



At 31 March 2025

11,908
6,174
18,082



Depreciation


At 1 July 2024
6,193
4,229
10,422


Charge for the period on owned assets
476
146
622



At 31 March 2025

6,669
4,375
11,044



Net book value



At 31 March 2025
5,239
1,799
7,038



At 30 June 2024
5,715
1,945
7,660

Page 6

 
IXWORTH MEDICAL SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025

5.


Debtors

31 March
30 June
2025
2024
£
£


Trade debtors
99,288
107,868

Amounts owed by group undertakings
33,241
39,816

Other debtors
10,911
10,860

Prepayments and accrued income
320
602

143,760
159,146



6.


Cash and cash equivalents

31 March
30 June
2025
2024
£
£

Cash at bank and in hand
29,079
60,958

29,079
60,958



7.


Creditors: Amounts falling due within one year

31 March
30 June
2025
2024
£
£

Payments received on account
36,246
53,217

Trade creditors
46,963
47,719

Corporation tax
-
4,074

Other taxation and social security
5,267
4,206

Accruals and deferred income
99,949
100,871

188,425
210,087


Page 7